Zika virus structure, maturation, and receptors

D Sirohi, RJ Kuhn - The Journal of infectious diseases, 2017 - academic.oup.com
The emergence of Zika virus (ZIKV) as a major public health threat has focused research on
understanding virus biology and developing a suite of strategies for disease intervention …

Receptors and routes of dengue virus entry into the host cells

C Cruz-Oliveira, JM Freire… - FEMS microbiology …, 2015 - academic.oup.com
Dengue is the most prevalent arthropod-borne viral disease, caused by dengue virus, a
member of the Flaviviridae family. Its worldwide incidence is now a major health problem …

Flavivirus receptors: diversity, identity, and cell entry

M Laureti, D Narayanan, J Rodriguez-Andres… - Frontiers in …, 2018 - frontiersin.org
Flaviviruses are emerging and re-emerging arthropod-borne pathogens responsible for
significant mortality and morbidity worldwide. The genus comprises more than seventy …

Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries

S Khongwichit, J Chansaenroj, C Chirathaworn… - Journal of Biomedical …, 2021 - Springer
Chikungunya virus (CHIKV) is a re-emerging mosquito-borne human pathogen that causes
chikungunya fever, which is typically accompanied by severe joint pain. In Asia, serological …

Structures and functions of the envelope glycoprotein in flavivirus infections

X Zhang, R Jia, H Shen, M Wang, Z Yin, A Cheng - Viruses, 2017 - mdpi.com
Flaviviruses are enveloped, single-stranded RNA viruses that widely infect many animal
species. The envelope protein, a structural protein of flavivirus, plays an important role in …

Antiviral drug discovery: broad-spectrum drugs from nature

JP Martinez, F Sasse, M Brönstrup, J Diez… - Natural product …, 2015 - pubs.rsc.org
Covering: up to April 2014 The development of drugs with broad-spectrum antiviral activities
is a long pursued goal in drug discovery. It has been shown that blocking co-opted host …

Molecular mechanisms of antiviral agents against dengue virus

MF Lee, YS Wu, CL Poh - Viruses, 2023 - mdpi.com
Dengue is a major global health threat causing 390 million dengue infections and 25,000
deaths annually. The lack of efficacy of the licensed Dengvaxia vaccine and the absence of …

A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins

G Fibriansah, JL Tan, SA Smith, R De Alwis… - Nature …, 2015 - nature.com
Abstract Dengue virus (DENV) infects~ 400 million people annually. There is no licensed
vaccine or therapeutic drug. Only a small fraction of the total DENV-specific antibodies in a …

Current status and perspectives on vaccine development against dengue virus infection

J Park, J Kim, YS Jang - Journal of Microbiology, 2022 - Springer
Dengue virus (DENV) consists of four serotypes in the family Flaviviridae and is a causative
agent of dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. DENV is …

The medicinal chemistry of dengue virus

MAM Behnam, C Nitsche, V Boldescu… - Journal of medicinal …, 2016 - ACS Publications
The dengue virus and related flaviviruses are an increasing global health threat. In this
perspective, we comment on and review medicinal chemistry efforts aimed at the prevention …